PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'WACEM-ACAIM Joint Global COVID-19 Taskforce- Immunology Division, USA.\', \'Department of Emergency Medicine, Florida State University Sarasota Memorial Hospital, Sarasota, Florida.\', \'Section General and Acute Internal Medicine, Department of Internal Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, The Netherlands.\', \'Department of Medical-Surgery Sciences and Translational Medicine, University La Sapienza Rome, Rome, Italy.\', \'Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland.\', \'Department of Research & Innovation, St. Luke\'s University Health Network, Bethlehem, Pennsylvania.\', \'Department of Surgery, The University of Alabama at Birmingham, Birmingham, Alabama.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/SHK.0000000000001627
?:hasPublicationType
?:journal
  • Shock (Augusta, Ga.)
is ?:pmid of
?:pmid
?:pmid
  • 32649367
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all